dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorMoraes, Carolina Morales
dc.creatorde Lima, Renata
dc.creatorRosa, Andre Henrique
dc.creatorde Paula, Eneida
dc.creatorFraceto, Leonardo Fernandes
dc.date2014-05-20T13:12:12Z
dc.date2016-10-25T16:32:33Z
dc.date2014-05-20T13:12:12Z
dc.date2016-10-25T16:32:33Z
dc.date2009-01-01
dc.date.accessioned2017-04-05T19:16:04Z
dc.date.available2017-04-05T19:16:04Z
dc.identifierMacromolecular Symposia. Weinheim: Wiley-v C H Verlag Gmbh, v. 281, p. 106-112, 2009.
dc.identifier1022-1360
dc.identifierhttp://hdl.handle.net/11449/185
dc.identifierhttp://acervodigital.unesp.br/handle/11449/185
dc.identifier10.1002/masy.200950714
dc.identifierWOS:000268989100015
dc.identifier0000-0002-2042-018X
dc.identifierhttp://dx.doi.org/10.1002/masy.200950714
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/850551
dc.descriptionLocal anesthetic agents cause temporary blockade of nerve impulses productiong insensitivity to painful stimuli in the area supplied by that nerve. Bupivacaine (BVC) is an amide-type local anesthetic widely used in surgery and obstetrics for sustained peripheral and central nerve blockade. in this study, we prepared and characterized nanosphere formulations containing BVC. To achieve these goals, BVC loaded poly(DL-lactide-co-glycolide) (PLGA) nanospheres (NS) were prepared by nanopreciptation and characterized with regard to size distribution, drug loading and cytotoxicity assays. The 2(3-1) factorial experimental design was used to study the influence of three different independent variables on nanoparticle drug loading. BVC was assayed by HPLC, the particle size and zeta potential were determined by dynamic light scattering. BVC was determined using a combined ultrafiltration-centrifugation technique. The results of optimized formulations showed a narrow size distribution with a polydispersivity of 0.05%, an average diameter of 236.7 +/- 2.6 nm and the zeta potential -2.93 +/- 1,10 mV. In toxicity studies with fibroblast 3T3 cells, BVC loaded-PLGA-NS increased cell viability, in comparison with the effect produced by free BVC. In this way, BVC-loaded PLGA-NS decreased BVC toxicity. The development of BVC formulations in carriers such as nanospheres could offer the possibility of controlling drug delivery in biological systems, prolonging the anesthetic effect and reducing toxicity.
dc.languageeng
dc.publisherWiley-v C H Verlag Gmbh
dc.relationMacromolecular Symposia
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectbupivacaine
dc.subjectlocal anesthetic
dc.subjectpolymeric nanoparticle
dc.subjectpoly(DL-lactide-co-glycolide) nanospheres
dc.titleEncapsulation of Local Anesthetic Bupivacaine in Biodegradable Poly(DL-lactide-co-glycolide) Nanospheres: Factorial Design, Characterization and Cytotoxicity Studies
dc.typeOtro


Este ítem pertenece a la siguiente institución